BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2011
View Archived Issues
Frizzled FZD3 receptor expression as a biomarker of CRC and colorectal adenoma
Read More
Novel protein kinase inhibitors described at sanofi-aventis
Read More
ELGEN-1000-delivered DNA vaccines cleared to enter phase II leukemia trial in U.K.
Read More
Genzyme divests diagnostics and pharmaceutical intermediates businesses
Read More
Optic nerve sheath CSF flow dynamics as an imaging biomarker of IIH
Read More
Scientists generate stable aqueous nanocolloids to improve delivery of anticancer agents
Read More
New bombesin BB3 receptor agonist MK-5046 shows preclinical potential to treat obesity
Read More
Concert Pharma develops new deuterated GABA(A) receptor modulators
Read More
Arena Pharma claims new lysophospholipid S1P1 receptor agonists
Read More
Prolia available in Quebec for postmenopausal osteoporosis
Read More
Perseid Therapeutics begins phase I trial for CTLA4-Ig program
Read More
EMA approves sublingual sildenafil formulation X-Excite for erectile dysfunction
Read More
New GPR119 receptor agonists presented
Read More
Sinovac Biotech files clinical trial application in China for 23- and 24-valent PPVs
Read More
Zymenex's Lamazym advances to phase II in alpha-mannosidosis
Read More
Encouraging interim phase II data on Medicago's H5N1 vaccine
Read More
Prolor's factor IX-CTP shows promise in model of hemophilia
Read More
Isis Pharma begins phase I trial of ISIS-FXIRx for clotting disorders
Read More
Enrollment started in Aveo Pharma's phase II tivozanib biomarker trial
Read More
Enrollment halted in INSPIRE trial of necitumumab in advanced NSCLC
Read More
Temple University divulges new leptin receptor agonists
Read More
Sunovion set to launch Latuda in U.S. for schizophrenia
Read More
New inhibitors claimed of RAC-alpha serine/threonine-protein kinase phosphorylation
Read More
Pegasys/Copegus combination to get priority review in Japan for new indication
Read More
Otuska Pharma begins Japanese phase II OCV-101 trial in pancreatic cancer
Read More